GRAZ, Austria, June 6, 2011 /PRNewswire/ --

CNSystems from Graz, the leading medical technology company will bring a sensation to the world's attention in June. The company will be presenting its further developed CNAP technology at the International Congress of the European Society of Anaesthesiology in Amsterdam, which not only offers continuous, noninvasive blood pressure measurement, but it also monitors the fluid status during operations.

CNAP(R)-PPV is the latest generation of the CNAP (Continuous Noninvasive Arterial Pressure) technology invented by CNSystems. Like the first generation, the new device also measures noninvasive blood pressure for each heartbeat using finger sensors. An additional function is the continuous measurement of the patient's fluid status during operations. "Anaesthesiologists know that a fluid deficit has a negative consequence on the circulation. Here our device proves its worth: it monitors both, blood pressure and fluid balance continuously. In case of a deficit, an infusion can be administered and therefore complications be avoided," the head of CNSystems, Jürgen Fortin, explains how the new device works.

"CNAP-PPV should extend the positive outcome of goal-directed fluid management beyond high-risk, arterial-line or Doppler-monitored surgeries. This would allow fluid management to become an actual and routine clinical standard for the benefit of the anesthetized patients," explains university professor Benoit Vallet, head of the Department of Anaesthesiology and Intensive Care at the Lille University Hospital, France, who tested CNAP(R)-PPV thoroughly.

39% of all operation patients would be eligible for this method of fluid management. CNAP(R)-PPV constitutes a cost-saving solution as this method decreases complications, optimises the treatment and ultimately reduces the number of hospitalisation-days.

So the device penetrates the fastest growing segment on the patient monitoring market. "More and more anaesthesiologists and health care managers recognise the potential of target-oriented fluid optimisation and the associated reduction of complications. This saves the health care system money and paves the way for our innovation," explains Fortin.

Further information at: http://www.cnsystems.at

CNSystems is an Austrian medical technology company and technological leader in noninvasive, continuous blood pressure measurement.

    
    Contact:
    Alice Wellisch
    CNSystems Medizintechnik AG
    Tel.: +43-316-723456-0
    E-mail: office@cnsystems.at

SOURCE CNSystems Medizintechnik AG